Don’t Get “Patent Disease Syndrome”

There appears to be a disease going around called Patent Disease Syndrome (“PDS”).  It starts with a little round fur ball (also known as a “Wuppee”) which can either bring a smile to your face or confusion from the bombardment of billion-dollar infringement claims reported in the media (see picture of bug shot under microscope in a laboratory not too far away).


“Do Not Get Bitten By the Patent Disease Syndrome Bug”
Some Things You May Want to Know About the MMRGlobal Patent Portfolio and Did Not Know Who to Ask,” which appears below. MMR owns its products and services and relies on its IP to remain competitive in the marketplace.
 
As the Company’s CEO and the inventor of our patents, I am proud that we own a portfolio of five issued United States patents with hundreds of claims, as well as other similar health IT patents in at least 12 countries around the world. I also discussed what MMR’s Patent portfolio could mean to the health IT industry and our strategy of working to create strategic business partnerships by selling our products and services or enter into reasonable licensing agreements.

Our strategy is to enable patients to get the benefits of our untethered products so that they can access their personal health information wherever they are anywhere in the world.

In the weeks since that last Blog, Apple has won a billion dollars in a patent suit and now it looks like they may have to pay a chunk to someone else who appears to have won a patent suit from them. Every day, patent claims seem to dominate the headlines of business and trade press. Rather than thinking about hiding in the wake of all the patent IP wars, this Blog is intended to provide relief from what I call the Patent Disease Syndrome (“PDS”).

Patent Disease Syndrome is a very costly and time-consuming disease that can attack when least expected. A few simple preventative steps can protect you from ever having to deal with it.  First, preform an Intellectual Property Audit to protect your IP and protect you from infringing on anyone else’s. Then talk to an MMR patent specialist about why you should purchase or license MMR’s products and services or IP. MMR can help satisfy your quest for your share of the billion-dollar stimulus pie available to you by meeting Meaningful Use Stage 2 requirements. You’ll even find out how much money you can add with the MMR Stimulus program.

As we do in our everyday life, we insure our risks.  Licensing patents is nothing more than paying for the annual software license to prevent your system from getting a virus.  Patents are becoming an important factor in purchasing decisions pertaining to Health IT. Having licenses upfront before the bug bites may be one of the smartest things a hospital or healthcare professional can do and could be a lot cheaper than litigating over them in the future.

So don’t get bitten by the Patent Disease Syndrome bug.  Simply put, patents give patent holders the right to exclude others from using intellectual property that may be part of a product or service you use.  Clearly, in an industry the size of Health IT, that is going to happen. Being aware of risks associated with patent infringement is smart business.

If you would like your own limited edition canister, as shown above, designed by world-famous artist Charles Bragg, filled with Patent Disease Syndrome Bugs, contact investor relations at the email address below and we will send it along.

For specific information about the Company’s patents, which include U.S. Patent Nos. 8,121,855, 8,117,646, 8,117,045, 8,301,466 and 8,321,240, contact Ted Ward at Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP, (Tel. 310-500-3384 / TWard@LinerLaw.com) or me at the contact information that appears below.

 Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010, Tel. 310-476-7002
info@mmrmail.com
www.mmrglobal.com

 

Leave a Reply

You must be logged in to post a comment.